OmniAb SPAC Presentation Deck

KEY MARKET COMPARABLES SUGGEST SUBSTANTIAL VALUE CREATION OPPORTUNITY Enterprise Value ($) in millions $1,961 ($835 Diversified Drug Discovery 252(1) Private Ligand OmniAb ADIMAB # of Active Programs 425 (2) $4,844 evotec 111 Source: Company materials, filings, and FactSet as of 03/18/22. (1) Includes 248 active programs with downstream economics. $2,216 AbCellera 78(3) (2) Includes total program initiations, Adimab does not disclose current active program count. (3) Includes 54 active programs with downstream economics. (4) Includes 3 programs from recent Merck collaboration. $567 absci. 12(4) Computationally-Enabled Drug Discovery $2,095 $1,878 $1,301 RELAY SCHRÖDINGER Exscientia HERAPEU ES Next-Generation Discovery and Production Technologies $3,726 GINKGO BIOWORKS $2,616 TWIST BIOSCIENCE $1,313 $1,203 CODEXIS Adaptive PROTEIN ENGINEERING EXPERTS 7 OmniAb

View entire presentation